331 related articles for article (PubMed ID: 33262120)
1. A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo.
Yan C; Tian X; Li J; Liu D; Ye D; Xie Z; Han Y; Zou MH
Diabetes; 2021 Feb; 70(2):577-588. PubMed ID: 33262120
[TBL] [Abstract][Full Text] [Related]
2. Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte.
Wu J; Dong T; Chen T; Sun J; Luo J; He J; Wei L; Zeng B; Zhang H; Li W; Liu J; Chen X; Su M; Ni Y; Jiang Q; Zhang Y; Xi Q
Metabolism; 2020 Feb; 103():154006. PubMed ID: 31715176
[TBL] [Abstract][Full Text] [Related]
3. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease.
Koeck ES; Iordanskaia T; Sevilla S; Ferrante SC; Hubal MJ; Freishtat RJ; Nadler EP
J Surg Res; 2014 Dec; 192(2):268-75. PubMed ID: 25086727
[TBL] [Abstract][Full Text] [Related]
5. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice.
Sakane S; Hikita H; Shirai K; Myojin Y; Sasaki Y; Kudo S; Fukumoto K; Mizutani N; Tahata Y; Makino Y; Yamada R; Kodama T; Sakamori R; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1683-1699. PubMed ID: 34303881
[TBL] [Abstract][Full Text] [Related]
6. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M
Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674
[No Abstract] [Full Text] [Related]
7. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.
Pan X; Wang P; Luo J; Wang Z; Song Y; Ye J; Hou X
Endocrine; 2015 Apr; 48(3):834-47. PubMed ID: 25138963
[TBL] [Abstract][Full Text] [Related]
8. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
[TBL] [Abstract][Full Text] [Related]
9. Boesenbergia pandurata attenuates diet-induced obesity by activating AMP-activated protein kinase and regulating lipid metabolism.
Kim DY; Kim MS; Sa BK; Kim MB; Hwang JK
Int J Mol Sci; 2012; 13(1):994-1005. PubMed ID: 22312299
[TBL] [Abstract][Full Text] [Related]
10. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
11. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
Hong Y; Choi SI; Hong E; Kim GH
J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.
Liou CJ; Lee YK; Ting NC; Chen YL; Shen SC; Wu SJ; Huang WC
Cells; 2019 May; 8(5):. PubMed ID: 31083505
[TBL] [Abstract][Full Text] [Related]
13. Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice.
Wu Z; Tan J; Chi Y; Zhang F; Xu J; Song Y; Cong X; Wu N; Liu Y
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G659-G670. PubMed ID: 29902065
[TBL] [Abstract][Full Text] [Related]
14. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
16. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
[TBL] [Abstract][Full Text] [Related]
17. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
18. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
19. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
Chen K; Chen X; Xue H; Zhang P; Fang W; Chen X; Ling W
Food Funct; 2019 Feb; 10(2):814-823. PubMed ID: 30675881
[TBL] [Abstract][Full Text] [Related]
20. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.
Kim J; Lee H; Lim J; Oh J; Shin SS; Yoon M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
